Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Colchicine Binding Site Tubulin Inhibitors Impair Vincristine-Resistant Neuroblastoma Cell Function

Molecules(2025)10.3390/molecules30102186Source: DataRank Database

Colchicine Binding Site Tubulin Inhibitors Impair Vincristine-Resistant Neuroblastoma Cell Function is a research paper published in Molecules (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.55)OA: goldTopics (45)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kaylee B. Garrison,Joshua Thammathong,Jindřich Činátl ORCID,Martin Michaelis ORCID,Souvik Banerjee ORCID

Live enrichment

PubMed:40430358 OpenAlex:https://openalex.org/W4410440473

NIH/NCI

Grant: CA263868

NIH/NCI

Grant: GM154786

National Institutes of Health

Grant: 1R15CA263868-01

Determining the significance of the N-MYC-WDR5 interaction in neuroblastoma.

National Institutes of Health

Grant: 5R16GM154786-02

Discovery of fused heterocyclic pyrazine based novel anti-mitotic agents for metastatic melanoma

FWCI

1.55

Citation Percentile

0.8%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/30/10/2186/pdf?version=1747394271

publisherhttps://www.mdpi.com/1420-3049/30/10/2186/pdf?version=1747394271

publisherhttps://www.mdpi.com/1420-3049/30/10/2186/pdf

journalhttps://doi.org/10.3390/molecules30102186

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40430358

Fields of Study

Neuroblastoma Research and TreatmentsCancer therapeutics and mechanismsLung Cancer Research Studies03 medical and health sciences0302 clinical medicine

MeSH Terms

Binding SitesColchicineHumansNeuroblastomaTubulinVincristineApoptosisDrug Resistance, NeoplasmCell Line, TumorCell ProliferationTubulin Modulators

Keywords

VincristineTubulinNeuroblastomaColchicineCancer researchPharmacologyCell cultureMedicineBiologyChemotherapyOncologyMicrotubuleInternal medicineCell biologyGeneticsCyclophosphamideBinding Sites<i>MYCN</i>Organic chemistryApoptosis<i>ALK</i>ArticleTubulin ModulatorsQD241-441Drug Resistance, NeoplasmCell Line, TumorHumanscolchicine binding site inhibitorCell Proliferation

Sustainable Development Goals

SDG 0: Good health and well-being